STOCK TITAN

01 Quantum Announces Election of Dr. Edoardo Persichetti to Board of Directors

(Neutral)
(Positive)
Tags
management

01 Quantum (OTCQB: OONEF, TSXV: ONE) announced the election of Dr. Edoardo Persichetti to its Board of Directors following shareholder approval on April 30, 2026. Dr. Persichetti brings post-quantum cryptography expertise and served as a consultant. The company granted options to buy 100,000 shares at $0.43, vesting quarterly through April 28, 2028, bringing total options outstanding to 9,205,000.

Persichetti is an associate professor and co-author of HQC, selected as a NIST global standard in 2025, and previously participated in NIST's standardization process.

Loading...
Loading translation...

Positive

  • Board expertise: Addition of Dr. Edoardo Persichetti, PQC specialist and NIST contributor
  • Technical credibility: Co-author of HQC, selected as a global NIST standard in 2025
  • Continuity: Persichetti transitions from consultant to director, supporting the technical roadmap

Negative

  • Option grant: 100,000 options granted at $0.43, vesting through April 28, 2028
  • Options outstanding: Total of 9,205,000 options under the stock option plan after grant

News Market Reaction – OONEF

-2.71%
-2.71% Session close to close

In the Apr 30 session, OONEF declined 2.71%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - 01 Quantum Inc. (TSXV: ONE) (OTCQB: OONEF) ("01 Quantum" or the "Company"), one of the first-to-market, enterprise level cybersecurity providers for the quantum computing era, is pleased to announce that Dr. Edoardo Persichetti has been elected to the Company's Board of Directors following shareholder approval at its annual meeting. Dr. Persichetti, who previously served as a consultant for the Company, brings world-class expertise in post-quantum cryptography (PQC) to the Board as 01 Quantum continues to scale its enterprise-level cybersecurity solutions.

"We are delighted to welcome Edoardo to the Board of Directors," said Andrew Cheung, CEO of 01 Quantum. "His transition from a strategic advisor to a Director reflects the value he provides to our technical roadmap. As a leading voice in NIST's standardization process, his oversight will be instrumental as we deploy IronCAP™ across security-sensitive enterprise environments."

Dr. Persichetti added, "Having worked closely with the team over the past year, I am honored to join the Board and help guide the Company's strategic vision. The arrival of quantum computing necessitates a fundamental shift in encryption, and 01 Quantum is positioned for that transition with practical, patent-protected solutions."

Dr. Persichetti is a renowned researcher in code-based cryptography and currently serves as an Associate Professor at Florida Atlantic University. He is a co-author of several algorithms submitted to the NIST Post-Quantum Standardization process, including HQC, which was selected as a global standard in 2025. His extensive academic background includes a PhD from the University of Auckland and research positions at Warsaw University. In connection with his appointment, on April 28 2026, the Company granted Dr. Persichetti options to purchase up to 100,000 common shares at a price of $0.43 per share for a period of four years from the date of grant. The options vest quarterly in four tranches of 25,000 each on October 28, 2026; April 28, 2027; October 28, 2027 and April 28, 2028. The options are governed by the provisions of the Company's stock option plan and the policies of the TSX-V. After granting these stock options there will be a total of 9,205,000 options outstanding under the stock option plan.

About 01 Quantum Inc.

01 Quantum Inc., formerly 01 Communique Laboratory Inc. (TSXV: ONE) (OTCQB: OONEF), is known for its innovative work in post-quantum cryptography (PQC), developing technologies designed to protect digital systems against emerging quantum computing threats. The Company's IronCAP™ and supporting technologies are integrated into its PQC solutions, enabling applications across security-sensitive environments including digital assets, AI systems, email security, and enterprise infrastructure.

IronCAP™ technologies are patent-protected in the U.S.A. by patents #11,271,715 and #11,669,833.

For more information, visit the Company's website at https://01com.com.

Cautionary Note Regarding Forward-Looking Statements.

Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "feel", "plan", "intend", "are confident" and other similar terminology. Such statements include statements regarding the ability to advance the Company's PQC technologies, the market adoption of such technologies and the impact of quantum computing on the digital economy. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk and Uncertainties" in the Company's Management`s Discussion and Analysis document filed on SEDAR+. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances.

Neither TSX Venture Exchange (TSX-V) nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

For additional information, please contact:

Brian Stringer
Chief Financial Officer
01 Quantum Inc.
(905) 795-2888 x204
Brian.stringer@01com.com

Sean Peasgood
Investor Relations
Sophic Capital
49 Wellington St. E, Suite 500
Toronto, ON M5E 1C9
(437) 295-1701
Sean@SophicCapital.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294886

FAQ

Who is Dr. Edoardo Persichetti and why was he elected to 01 Quantum's board (OONEF)?

He is an associate professor and PQC researcher elected to the board after shareholder approval. According to the company, Persichetti co-authored HQC and has served as a consultant, bringing post-quantum cryptography expertise to support deployment of IronCAP across enterprise environments.

What stock options did 01 Quantum (OONEF) grant to Dr. Persichetti on April 28, 2026?

The company granted options to purchase 100,000 common shares at $0.43 per share for four years. According to the company, options vest quarterly in four tranches with final vesting on April 28, 2028, under the stock option plan and TSX-V policies.

How many options will be outstanding for 01 Quantum (OONEF) after Dr. Persichetti's grant?

After the grant there will be 9,205,000 options outstanding under the company's stock option plan. According to the company, this total reflects all options outstanding following the April 28, 2026 grant to Persichetti.

What is Dr. Persichetti's connection to NIST and HQC mentioned by 01 Quantum (OONEF)?

Dr. Persichetti is a contributing researcher in NIST's post-quantum standardization process and co-authored HQC. According to the company, HQC was selected as a global NIST standard in 2025, underscoring his role in PQC standard-setting.

What role will Dr. Persichetti play at 01 Quantum (OONEF) after joining the board?

He will serve as a director providing oversight on the company's technical roadmap and product deployment. According to the company, his experience in post-quantum cryptography will be instrumental as 01 Quantum scales enterprise security solutions like IronCAP.

When do Dr. Persichetti's awarded options vest and what are the vesting dates for 01 Quantum (OONEF)?

The options vest quarterly in four tranches of 25,000 shares each on October 28, 2026; April 28, 2027; October 28, 2027; and April 28, 2028. According to the company, the options are subject to the stock option plan and TSX-V policies.